Nazneen Aziz, PhD. Director, Molecular Medicine Transformation Program Office

Size: px
Start display at page:

Download "Nazneen Aziz, PhD. Director, Molecular Medicine Transformation Program Office"

Transcription

1 2013 Laboratory Accreditation Program Audioconferences and Webinars Implementing Next Generation Sequencing (NGS) as a Clinical Tool in the Laboratory Nazneen Aziz, PhD Director, Molecular Medicine Transformation Program Office February 20, 2013

2 Topics Next Generation Sequencing o Technology overview o Rapidly evolving field o Factors driving adoption of NGS in diagnostic medicine o CAP/CLIA standards developed for NGS o NGS methods based PT in development 2013 College of American Pathologists. All rights reserved. 2

3 Introduction to Next Generation Sequencing Overview: History Human genome Project led the path to genomic medicine ( ) Now Human Genome Project 13 years $3 billion Research Applications Genomic medicine Sequence Compare Report Predict and diagnose diseases 2013 College of American Pathologists. All rights reserved. 3

4 Sanger Sequencing: Autoradiography Chromatograms The Human Genome Project (first reference sequence) was done using Sanger sequencing College of American Pathologists. All rights reserved. 4

5 Sanger vs Next Generation Sequencing Sanger Next Generation Sequencing 2013 College of American Pathologists. All rights reserved. 5

6 Sanger vs Next Generation Sequencing 2013 College of American Pathologists. All rights reserved. 6

7 Illumina Genome Analyzer Compiled Image A T C G Flow Cell Clusters

8 Qualitative and Quantitative Information G> A Illumina Ref Seq Coverage or number of reads 8

9 Next Generation Sequencing Bioinformatics Image Capture Variant Identification Annotation Giga-Terabyte Image Processing Conversion to Bases Base Quality Scores Sequence Read Files Signal to Noise 2013 College of American Pathologists. All rights reserved. 9

10 Rapid Evolution of Next Generation Sequencers First Wave Second Wave 454/Roche 2005 Illumina Life Tech Helicos Pacific Biosciences GS FLX Genome Analyzer SOLiD HeliScope SMRT Third Wave GS Junior GAIIx GAIIe HiScanSQ HiSeq SOLiD 5500 SOLiD 5500xl Ion Torrent PGS Ion Proton miseq Proton

11 Sequencing Chemistries and Signals are Varied Pyrosequencing 454 Reversible Dye Terminators Illumina Sequencing by Ligation SOLiD Ion Torrent Generation of Luminescent or Fluorescent Images or chemical signals Conversion to Sequence 2013 College of American Pathologists. All rights reserved. 11

12 Illumina HiSeq Independent Flow Cells 8 Lanes per Flow Cell Multiple Samples per Lane 2-3 Exome(s) per Lane 2 Genomes per Flow Cell 7 days/genome 2013 College of American Pathologists. All rights reserved. 12

13 New Platforms Lower throughput h t - faster turn around time Illumina miseq Ion Torrent PGM Reversible Dye Monitors H+ Terminators Release 2013 College of American Pathologists. All rights reserved. 13

14 Ion Proton DNA Sequencer Semiconductor chips form the heart of the machine. CMOS chips detect chemical changes instead of light. The Ion Proton I chip has 165 million sensors Mid The Ion Proton II Chip has 660 million sensors. Late Significant increase in speed and reduction of fthe cost of genome-level l sequencing College of American Pathologists. All rights reserved. 14

15 Oxford Nanopore: Single Molecule Sequencing 2013 College of American Pathologists. All rights reserved. 15

16 Alignment Software Academic Software In-house built Free Genome community support maq assemble [-sp] [-m maxmis] [-Q maxerr] [-r hetrate] [-t coef] [-q minq] [-N nhap] out.cns in.ref.bfa in.aln.map 2> out.cns.log Commercial Software Feature rich user interface $$$ Company support 2013 College of American Pathologists. All rights reserved. 16

17 Agenda Next Generation Sequencing o o Technology overview Rapidly evolving field o Factors driving i adoption of NGS in diagnostic medicine i o Standards developed for laboratory accreditation at CAP o NGS methods based PT in development 2013 College of American Pathologists. All rights reserved. 17

18 Growth in Sequencing Revenues: Genetic Testing Estimated to reach $5 billion : College of American Pathologists. All rights reserved. 18

19 The Cost of Genome Sequencing is Decreasing Rapidly and Driving Clinical Adoption of Genomic Analysis Cost per Genome Data Generation, Sep 2001 Oct 2011 $100,000, $10,000,000 $1,000,000 $100,000 $10,000 $1,000 Oct-01 Apr-02 Oct-02 Apr-03 Oct-03 Apr-04 Oct-04 Apr-05 Oct-05 Apr-06 Oct-06 Apr-07 Oct-07 Apr-08 Oct-08 Apr-09 Oct-09 Apr-10 Oct-10 Apr-11 Oct-11 Cost for genome sequence data generation today is <$3, College of American Pathologists. All rights reserved. Source: National Human Genome Research Institute 19

20 Decline in Sequencing Costs Likely to Continue 2013 College of American Pathologists. All rights reserved. 20

21 Genomic Analysis by Next Gen Sequencing Currently Used Past and Continuing Molecular Pathology Tests Single/Few Mutations Genomic Analysis: Most commonly used Gene Panels Genomic Analysis: Growing and perhaps common in the near future Genome Single Gene/Pathogen Exome Transcriptome Few Genes Genomic Analysis by Next Gen Sequencing 2013 College of American Pathologists. All rights reserved. 21

22 NGS Survey of CAP PT Customers 19% current users 55% plan to begin NGS 20% within 6 months 14% within 12 months 21% within 1 3 years 176 responders 19% do not plan to begin using NGS technology Of those using NGS technology, 61% perform less than 10 tests per month 2013 College of American Pathologists. All rights reserved. 22

23 Disease Area NGS Tests 2012 College of American Pathologists. All rights reserved. 23

24 NGS Tests Offered: Panel, Exome, Genome 2013 College of American Pathologists. All rights reserved. 24

25 Expansion Plans of NGS Test Offered 2013 College of American Pathologists. All rights reserved. 25

26 Confirmation Using Alternate Technologies 41% always use Sanger or other technologies to confirm pathogenic variants prior to reporting 22% use it only for specific cases/assays 2013 College of American Pathologists. All rights reserved. 26

27 Bioinformatics Support 30% require outsourced bioinformatics support 2013 College of American Pathologists. All rights reserved. 27

28 Clinical Genomic Analysis Process Pre-Analytical Sequence Data Generation Sequence Data Interpretation Reporting & Billing Clinical Consultation 2013 College of American Pathologists. All rights reserved. 28

29 Pre-Analytical aytca Determine if testing ti is clinically i ll useful Determine appropriate p test, specimen, and laboratory Obtain sample and patient consent 2013 College of American Pathologists. All rights reserved. 29

30 Sequence Data Generation Sequencing Process Data QA & Sequence Alignment DNA extraction DNA fragmentation Fragment selection Adapter ligation Clonal amplification Sequencing Quality assessment of sequence data (depth of coverage, variant frequency, etc.) Align sequence data to reference sequence Identify variants based on reference sequence 6 Billion bases (maternal and paternal) 4 Million variants (10% complex variants: indels, SV, CNVs ) 2013 College of American Pathologists. All rights reserved. 30

31 Sequence Data Interpretation Variant tassessment Clinical i l Interpretation t ti Compare variants to databases (OMIM, COSMIC, dbsnp, 1000 Genomes, ENCODE, etc.) Variant impact analysis (evolutionary conservancy analysis, protein structural analysis, pathway analysis, etc.) Integration of potentially t significant variants with clinical phenotype of the patient, family, and literature Interpretive report generation Literature reviews 2013 College of American Pathologists. All rights reserved. 31

32 Reporting & Billing Report in LIS, EHR., and PHR Code and bill for testing & interpretation 20123College of American Pathologists. All rights reserved. 32

33 Clinical Consultation Physician i consults Clinical conferences Patient consultations with physician and genetic counselors 2013 College of American Pathologists. All rights reserved. 33

34 Clinical Genomic Analysis Process Sequence Data Generation Pre-Analytical Determine if testing is clinically useful Determine appropriate test, specimen, and laboratory Obtain/document patient consent Sequencing Process DNA extraction DNA fragmentation Fragment selection Adapter ligation Clonal amplification Sequencing Data QA & Sequence Alignment Quality assessment of sequence data (depth of coverage, variant frequency, etc.) Align sequence data to reference sequence Identify variants based on reference sequence 6 Billion bases (maternal and paternal) 4 Million variants (10% complex variants: indels, SV, CNVs ) Sequence Data Interpretation Variant Assessment Compare variants to databases (OMIM, COSMIC, dbsnp, 1000 Genomes, ENCODE, etc.) Variant impact analysis (evolutionary conservancy analysis, protein structural analysis, pathway analysis, etc.) Literature reviews Clinical Interpretation Reporting & Billing Clinical Consultation Integration of Report in LIS, Individual potentially EHR and PHR physician significant variants Code and bill consults with clinical, family, for testing & Clinical and literature interpretation Write interpretive report Conferences Patient consultations 2013 College of American Pathologists. All rights reserved. 34

35 CAP/CLIA Steps in Clinical Genomic Testing Process Work Flow Physician Genome CLIA lab Deliver data Patient orders IGS for patient Sequencing and QC delivers results to physician to patient Understands Implications CAP s standards in accreditation, PT services, reporting of NGS labs

36 Agenda Next Generation Sequencing o Technology overview o Rapidly evolving field o Factors driving adoption of NGS in diagnostic medicine o Standards developed for laboratory accreditation at CAP o NGS methods based PT in development 2013 College of American Pathologists. All rights reserved. 36

37 Why do we need to have standards for NGS clinical tests? Million variants/genome Dramatically increased complexity Test results need to capture not only the unique genetic differences but also the patterns of differences 2013 College of American Pathologists. All rights reserved. 37

38 NGS Work Group Charter 1 Identify, Refine, and drecommend dlaboratory Accreditation ti Standards for the Analytical and Bioinformatics Workflow for Clinical Tests Using NGS 2 Recommend Proficiency Testing Protocols, Reference Materials, and Product Development 3 Other Goals: Adapt to Meet Growing Questions/Needs Raised by Next Generation Sequencing 2013 College of American Pathologists. All rights reserved. 38

39 Process We Follow Employ Existing Applicable Requirements Introduce New Requirements Where Needed Find the Right Balance 2013 College of American Pathologists. All rights reserved. 39

40 Next Generation Sequencing: Steps in Workflow Analytical Wet Bench Process: sample handling, library preparation, sequence generation Bioinformatics process: Alignment, variant calling, and variant annotation Clinical Interpretation 2013 College of American Pathologists. All rights reserved. 40

41 NGS Accreditation Checklist Themes: Documentation Test Validation Quality control and quality assurance Traceability of test results reported (instrument, chemistry, versions) Exceptional log - test samples Confirmatory testing using an alternate method during validation Monitoring and implementing- upgrades to the chemistry or bioinformatics software Data storage and data transfer cloud computing and HIPAA Clinical interpretation of variants - using professional guidelines Reporting of unexpected and significant findings (incidental findings) 2013 College of American Pathologists. All rights reserved. 41

42 MOL.XXX02 The laboratory validates the analytical wet bench process and revalidates after changes or upgrades to any components used to generate next-generation sequencing data. NOTE: Validation of the analytical wet bench process can be method-based or analyte-specific and must describe required performance characteristics of the entire analytical process and individual process steps. Revalidation may cover all or a subset of steps in the process depending on the extent of the modification. Acceptance criteria for analytical runs must be established. Validations must include information on the analytical target (examples: exons, genes, exomes, genomes, transcriptomes). The ability of the analytical process to sequence the target (e.g., percentage of target adequately sequenced) must be described. Validations must determine and document analytical sensitivity, specificity, reproducibility, repeatability and precision for the types of variants assayed (e.g., single nucleotide variants, insertions and deletions, homopolymer or repetitive sequences). Interference by clinically relevant pseudogenes and other sequences highly homologous to the target must be determined and documented. Sequencing error rates (i.e., false positives and false negatives) for variants assayed must be determined and documented using an alternative method which may include an alternate NGS chemistry. Indexing (bar coding) and sample pooling methods must be validated to ensure that individual sample identity is maintained throughout the analytical wet bench process. Evidence of compliance: Records of validation and revalidation studies 2013 College of American Pathologists. All rights reserved. 42

43 MOL.34936: Validation - Wet Bench Analytical The laboratory validates the analytical wet bench process and revalidates after changes or upgrades to any components used to generate next generation sequencing data Validations must determine and document analytical sensitivity, specificity, reproducibility, repeatability and precision for the types of variants assayed (e.g. single nucleotide variants, insertions and deletions, homopolymer or repetitive sequences). Interference by clinically relevant pseudogenes and other sequences highly homologous to the target must be determined and documented. Sequencing error rates (i.e. false positives and false negatives) for variants assayed must be determined and documented using an alternative method which may include an alternate NGS chemistry. Indexing I d i (barcoding) and sample pooling methods must be validated d to ensure that individual sample identity is maintained throughout the analytical wet bench process. 43

44 MOL.34940: Confirmatory Testing The laboratory has a policy for when confirmatory testing of identified d or reported variants will be determined d by an alternative method. The laboratory maintains an ongoing record of the sensitivity, specificity, false positives, false negatives, reproducibility and repeatability of results and compares these with data obtained during the validation process. Evidence of Compliance: Policy or procedure that describes the indications for confirmatory testing College of American Pathologists. All rights reserved. 44

45 MOL.34944: Patient t Reports The specific methods, instrument(s) and reagents are traceable for each patient t report College of American Pathologists. All rights reserved. 45

46 MOL.34948: Monitoring i of Upgrades The laboratory has a policy for monitoring and implementing upgrades to instruments, sequencing chemistries, and reagents or kits used to generate next generation sequence data College of American Pathologists. All rights reserved. 46

47 MOL Sequence Variants: Interpretation/Reporting Interpretation and reporting of sequence variants takes into consideration professional organizations' recommendations and guidelines. The laboratory should have a decision making process for classifying and interpreting pathogenic variants, potential pathogenic variants, benign variants, and variants of unknown clinical significance College of American Pathologists. All rights reserved. 47

48 MOL.34954: Clinically i ll Significant ifi Genetic Findings The laboratory has a policy regarding reporting of clinically significant genetic findings unrelated to the clinical purpose for testing. Gene panel(s), exome, transcriptome, and genome sequencing may yield unexpected (or incidental) clinically significant genetic findings unrelated to the disorder for which the patient is undergoing testing College of American Pathologists. All rights reserved. 48

49 MOL.34958: Process/Pipeline Documentation ti The laboratory documents the bioinformatics process or pipeline(s) used to support the analysis, interpretation, and reporting of next generation sequencing based results. A bioinformatics process or pipeline includes all algorithms, software, scripts, database packages, reference sequences, and databases whether in-house developed, vendordeveloped and/or supported or open source. Flow diagrams may be helpful in providing a graphical overview of processes. Documentation used to support clinical operations must include: The individual applications used, with versions and appropriate command line flags or other configuration items that deviate from the standard, baseline installation Additional scripts or steps used to connect discrete applications Description of input and output data files or information in each process step Metrics and QC parameters for optimal performance Criteria for variant calling 2013 College of American Pathologists. All rights reserved. 49

50 MOL.34968: Version Traceability The specific version(s) of the bioinformatics process or pipeline(s) used to generate next generation sequencing data are traceable for each patient report. Details of the version of the bioinformatics process or pipeline used to generate each patient report may utilize a laboratory-specific system that refers to the entire process or pipeline, as well as changes to the versions of the individual components within the process or pipeline College of American Pathologists. All rights reserved. 50

51 MOL.34972: Data Transfer Confidentiality Policy There are procedures in place to ensure that internal and external storage and transfer of sequencing data provides reasonable confidentiality and security, and conforms to patient confidentiality requirements. It is recognized that laboratories may transfer data to external laboratories and other service providers for storage and analysis. This may include data storage and analysis through cloud-based computing. Procedures to ensure confidentiality might include message security, system and user authentication, activity logs, encryption, and access restrictions College of American Pathologists. All rights reserved. 51

52 Agenda Next Generation Sequencing o Technology overview o Rapidly evolving field o Factors driving adoption of NGS in diagnostic medicine o Standards developed for laboratory accreditation at CAP o NGS methods based PT in development 2013 College of American Pathologists. All rights reserved. 52

53 Plans for Proficiency Testing in NGS Offer a pilot product in 2013 Learn from this offering: Technology platforms used WGS, Exome, gene panels used Troubleshoot Full fledged PT offering by College of American Pathologists. All rights reserved. 53

54 Types of Next Generation Sequencing PT Analytical Wet Bench Process: sample handling, library preparation, sequence generation Bioinformatics process: Alignment, variant calling, and variant annotation Wet challenge Dry challenge Total challenge Clinical Interpretation 2013 College of American Pathologists. All rights reserved. 54

55 Relevant White Papers Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing. A Report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics. Vol. 14, No. 6, November Assuring the quality of next-generation sequencing in clinical laboratory practice. Nature Biotechnology. Vol. 30, No. 11, November College of American Pathologists. All rights reserved. 55

56 Acknowledgements Karl Voelkerding for some slides on NGS methods NGS Work Group at CAP for development of the NGS checklist The Case-for-Change M4 Team at CAP for some slides 2013College of American Pathologists. All rights reserved. 56

Next Generation Sequencing

Next Generation Sequencing Next Generation Sequencing Technology and applications 10/1/2015 Jeroen Van Houdt - Genomics Core - KU Leuven - UZ Leuven 1 Landmarks in DNA sequencing 1953 Discovery of DNA double helix structure 1977

More information

Introduction to next-generation sequencing data

Introduction to next-generation sequencing data Introduction to next-generation sequencing data David Simpson Centre for Experimental Medicine Queens University Belfast http://www.qub.ac.uk/research-centres/cem/ Outline History of DNA sequencing NGS

More information

Next generation DNA sequencing technologies. theory & prac-ce

Next generation DNA sequencing technologies. theory & prac-ce Next generation DNA sequencing technologies theory & prac-ce Outline Next- Genera-on sequencing (NGS) technologies overview NGS applica-ons NGS workflow: data collec-on and processing the exome sequencing

More information

Introduction to NGS data analysis

Introduction to NGS data analysis Introduction to NGS data analysis Jeroen F. J. Laros Leiden Genome Technology Center Department of Human Genetics Center for Human and Clinical Genetics Sequencing Illumina platforms Characteristics: High

More information

Data Analysis for Ion Torrent Sequencing

Data Analysis for Ion Torrent Sequencing IFU022 v140202 Research Use Only Instructions For Use Part III Data Analysis for Ion Torrent Sequencing MANUFACTURER: Multiplicom N.V. Galileilaan 18 2845 Niel Belgium Revision date: August 21, 2014 Page

More information

Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice. Supplementary Guidelines

Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice. Supplementary Guidelines Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice Next-generation Sequencing: Standardization of Clinical Testing (Nex-StoCT) Workgroup Principles and Guidelines Supplementary

More information

Pathology Informatics Summit

Pathology Informatics Summit Pathology Informatics Summit Pathology Information Systems in Genomic Medicine May 5 th, 2015 Lynn Bry, MD, PhD Director, Center for Metagenomics and Crimson Core Associate Professor, Harvard Medical School

More information

July 7th 2009 DNA sequencing

July 7th 2009 DNA sequencing July 7th 2009 DNA sequencing Overview Sequencing technologies Sequencing strategies Sample preparation Sequencing instruments at MPI EVA 2 x 5 x ABI 3730/3730xl 454 FLX Titanium Illumina Genome Analyzer

More information

G E N OM I C S S E RV I C ES

G E N OM I C S S E RV I C ES GENOMICS SERVICES THE NEW YORK GENOME CENTER NYGC is an independent non-profit implementing advanced genomic research to improve diagnosis and treatment of serious diseases. capabilities. N E X T- G E

More information

Next Generation Sequencing: Technology, Mapping, and Analysis

Next Generation Sequencing: Technology, Mapping, and Analysis Next Generation Sequencing: Technology, Mapping, and Analysis Gary Benson Computer Science, Biology, Bioinformatics Boston University gbenson@bu.edu http://tandem.bu.edu/ The Human Genome Project took

More information

Shouguo Gao Ph. D Department of Physics and Comprehensive Diabetes Center

Shouguo Gao Ph. D Department of Physics and Comprehensive Diabetes Center Computational Challenges in Storage, Analysis and Interpretation of Next-Generation Sequencing Data Shouguo Gao Ph. D Department of Physics and Comprehensive Diabetes Center Next Generation Sequencing

More information

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? Giovanni Luca Scaglione, PhD ------------------------ Laboratory of Clinical Molecular Diagnostics and Personalized Medicine, Institute

More information

Delivering the power of the world s most successful genomics platform

Delivering the power of the world s most successful genomics platform Delivering the power of the world s most successful genomics platform NextCODE Health is bringing the full power of the world s largest and most successful genomics platform to everyday clinical care NextCODE

More information

NGS data analysis. Bernardo J. Clavijo

NGS data analysis. Bernardo J. Clavijo NGS data analysis Bernardo J. Clavijo 1 A brief history of DNA sequencing 1953 double helix structure, Watson & Crick! 1977 rapid DNA sequencing, Sanger! 1977 first full (5k) genome bacteriophage Phi X!

More information

Automated DNA sequencing 20/12/2009. Next Generation Sequencing

Automated DNA sequencing 20/12/2009. Next Generation Sequencing DNA sequencing the beginnings Ghent University (Fiers et al) pioneers sequencing first complete gene (1972) first complete genome (1976) Next Generation Sequencing Fred Sanger develops dideoxy sequencing

More information

SEQUENCING. From Sample to Sequence-Ready

SEQUENCING. From Sample to Sequence-Ready SEQUENCING From Sample to Sequence-Ready ACCESS ARRAY SYSTEM HIGH-QUALITY LIBRARIES, NOT ONCE, BUT EVERY TIME The highest-quality amplicons more sensitive, accurate, and specific Full support for all major

More information

Q&A: Kevin Shianna on Ramping up Sequencing for the New York Genome Center

Q&A: Kevin Shianna on Ramping up Sequencing for the New York Genome Center Q&A: Kevin Shianna on Ramping up Sequencing for the New York Genome Center Name: Kevin Shianna Age: 39 Position: Senior vice president, sequencing operations, New York Genome Center, since July 2012 Experience

More information

Go where the biology takes you. Genome Analyzer IIx Genome Analyzer IIe

Go where the biology takes you. Genome Analyzer IIx Genome Analyzer IIe Go where the biology takes you. Genome Analyzer IIx Genome Analyzer IIe Go where the biology takes you. To published results faster With proven scalability To the forefront of discovery To limitless applications

More information

Lectures 1 and 8 15. February 7, 2013. Genomics 2012: Repetitorium. Peter N Robinson. VL1: Next- Generation Sequencing. VL8 9: Variant Calling

Lectures 1 and 8 15. February 7, 2013. Genomics 2012: Repetitorium. Peter N Robinson. VL1: Next- Generation Sequencing. VL8 9: Variant Calling Lectures 1 and 8 15 February 7, 2013 This is a review of the material from lectures 1 and 8 14. Note that the material from lecture 15 is not relevant for the final exam. Today we will go over the material

More information

PreciseTM Whitepaper

PreciseTM Whitepaper Precise TM Whitepaper Introduction LIMITATIONS OF EXISTING RNA-SEQ METHODS Correctly designed gene expression studies require large numbers of samples, accurate results and low analysis costs. Analysis

More information

RETRIEVING SEQUENCE INFORMATION. Nucleotide sequence databases. Database search. Sequence alignment and comparison

RETRIEVING SEQUENCE INFORMATION. Nucleotide sequence databases. Database search. Sequence alignment and comparison RETRIEVING SEQUENCE INFORMATION Nucleotide sequence databases Database search Sequence alignment and comparison Biological sequence databases Originally just a storage place for sequences. Currently the

More information

Leading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik

Leading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik Leading Genomics Diagnostic harma Discove Collab Shanghai Cambridge, MA Reykjavik Global leadership for using the genome to create better medicine WuXi NextCODE provides a uniquely proven and integrated

More information

Single-Cell DNA Sequencing with the C 1. Single-Cell Auto Prep System. Reveal hidden populations and genetic diversity within complex samples

Single-Cell DNA Sequencing with the C 1. Single-Cell Auto Prep System. Reveal hidden populations and genetic diversity within complex samples DATA Sheet Single-Cell DNA Sequencing with the C 1 Single-Cell Auto Prep System Reveal hidden populations and genetic diversity within complex samples Single-cell sensitivity Discover and detect SNPs,

More information

Introduction to transcriptome analysis using High Throughput Sequencing technologies (HTS)

Introduction to transcriptome analysis using High Throughput Sequencing technologies (HTS) Introduction to transcriptome analysis using High Throughput Sequencing technologies (HTS) A typical RNA Seq experiment Library construction Protocol variations Fragmentation methods RNA: nebulization,

More information

All in a highly interactive, easy to use Windows environment.

All in a highly interactive, easy to use Windows environment. Database Providing: Accessibility Security Quality Control Review Variant Review Historical Library Variant Pathogenicity Prediction Laboratory Reporting Exportation to LIMS All in a highly interactive,

More information

Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD

Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD Director, Clinical Chemistry Molecular Diagnostics / Immunology Department of Laboratory Medicine Lahey Clinic Medical

More information

Genomic Medicine Education Initiatives of the College of American Pathologists

Genomic Medicine Education Initiatives of the College of American Pathologists Genomic Medicine Education Initiatives of the College of American Pathologists Debra G.B. Leonard, MD, PhD, FCAP Chair, Personalized Healthcare Committee, CAP Professor of Pathology, Weill Cornell Medical

More information

NGS Technologies for Genomics and Transcriptomics

NGS Technologies for Genomics and Transcriptomics NGS Technologies for Genomics and Transcriptomics Massimo Delledonne Department of Biotechnologies - University of Verona http://profs.sci.univr.it/delledonne 13 years and $3 billion required for the Human

More information

Final Project Report

Final Project Report CPSC545 by Introduction to Data Mining Prof. Martin Schultz & Prof. Mark Gerstein Student Name: Yu Kor Hugo Lam Student ID : 904907866 Due Date : May 7, 2007 Introduction Final Project Report Pseudogenes

More information

Specialty Lab Informatics and its role in a large academic medical center

Specialty Lab Informatics and its role in a large academic medical center Specialty Lab Informatics and its role in a large academic medical center Zoltan N. Oltvai, M.D. Associate Professor Department of Pathology University of Pittsburgh Disclosures I have no financial interest,

More information

ACMG clinical laboratory standards for next-generation sequencing

ACMG clinical laboratory standards for next-generation sequencing American College of Medical Genetics and Genomics ACMG Practice Guidelines ACMG clinical laboratory standards for next-generation sequencing Heidi L. Rehm, PhD 1,2, Sherri J. Bale, PhD 3, Pinar Bayrak-Toydemir,

More information

Focusing on results not data comprehensive data analysis for targeted next generation sequencing

Focusing on results not data comprehensive data analysis for targeted next generation sequencing Focusing on results not data comprehensive data analysis for targeted next generation sequencing Daniel Swan, Jolyon Holdstock, Angela Matchan, Richard Stark, John Shovelton, Duarte Mohla and Simon Hughes

More information

These case studies were developed by NHGRI and DO NOT REPRESENT official guidance for FDA regulations. IDE risk determinations will always depend on

These case studies were developed by NHGRI and DO NOT REPRESENT official guidance for FDA regulations. IDE risk determinations will always depend on These case studies were developed by NHGRI and DO NOT REPRESENT official guidance for FDA regulations. IDE risk determinations will always depend on the specifics of the study. Risk determinations PRESENTED

More information

LifeScope Genomic Analysis Software 2.5

LifeScope Genomic Analysis Software 2.5 USER GUIDE LifeScope Genomic Analysis Software 2.5 Graphical User Interface DATA ANALYSIS METHODS AND INTERPRETATION Publication Part Number 4471877 Rev. A Revision Date November 2011 For Research Use

More information

Automated Lab Management for Illumina SeqLab

Automated Lab Management for Illumina SeqLab Automated Lab Management for Illumina SeqLab INTRODUCTION Whole genome sequencing holds the promise of understanding genetic variation and disease better than ever before. In response, Illumina developed

More information

The Galaxy workflow. George Magklaras PhD RHCE

The Galaxy workflow. George Magklaras PhD RHCE The Galaxy workflow George Magklaras PhD RHCE Biotechnology Center of Oslo & The Norwegian Center of Molecular Medicine University of Oslo, Norway http://www.biotek.uio.no http://www.ncmm.uio.no http://www.no.embnet.org

More information

The Power of Next-Generation Sequencing in Your Hands On the Path towards Diagnostics

The Power of Next-Generation Sequencing in Your Hands On the Path towards Diagnostics The Power of Next-Generation Sequencing in Your Hands On the Path towards Diagnostics The GS Junior System The Power of Next-Generation Sequencing on Your Benchtop Proven technology: Uses the same long

More information

Targeted. sequencing solutions. Accurate, scalable, fast TARGETED

Targeted. sequencing solutions. Accurate, scalable, fast TARGETED Targeted TARGETED Sequencing sequencing solutions Accurate, scalable, fast Sequencing for every lab, every budget, every application Ion Torrent semiconductor sequencing Ion Torrent technology has pioneered

More information

Bioruptor NGS: Unbiased DNA shearing for Next-Generation Sequencing

Bioruptor NGS: Unbiased DNA shearing for Next-Generation Sequencing STGAAC STGAACT GTGCACT GTGAACT STGAAC STGAACT GTGCACT GTGAACT STGAAC STGAAC GTGCAC GTGAAC Wouter Coppieters Head of the genomics core facility GIGA center, University of Liège Bioruptor NGS: Unbiased DNA

More information

Genetic Analysis. Phenotype analysis: biological-biochemical analysis. Genotype analysis: molecular and physical analysis

Genetic Analysis. Phenotype analysis: biological-biochemical analysis. Genotype analysis: molecular and physical analysis Genetic Analysis Phenotype analysis: biological-biochemical analysis Behaviour under specific environmental conditions Behaviour of specific genetic configurations Behaviour of progeny in crosses - Genotype

More information

MiSeq: Imaging and Base Calling

MiSeq: Imaging and Base Calling MiSeq: Imaging and Page Welcome Navigation Presenter Introduction MiSeq Sequencing Workflow Narration Welcome to MiSeq: Imaging and. This course takes 35 minutes to complete. Click Next to continue. Please

More information

Disease gene identification with exome sequencing

Disease gene identification with exome sequencing Disease gene identification with exome sequencing Christian Gilissen Dept. of Human Genetics Radboud University Nijmegen Medical Centre c.gilissen@antrg.umcn.nl Contents Infrastructure Exome sequencing

More information

Tutorial for Windows and Macintosh. Preparing Your Data for NGS Alignment

Tutorial for Windows and Macintosh. Preparing Your Data for NGS Alignment Tutorial for Windows and Macintosh Preparing Your Data for NGS Alignment 2015 Gene Codes Corporation Gene Codes Corporation 775 Technology Drive, Ann Arbor, MI 48108 USA 1.800.497.4939 (USA) 1.734.769.7249

More information

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications Product Bulletin Sequencing Software SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications Comprehensive reference sequence handling Helps interpret the role of each

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Intro to Bioinformatics

Intro to Bioinformatics Intro to Bioinformatics Marylyn D Ritchie, PhD Professor, Biochemistry and Molecular Biology Director, Center for Systems Genomics The Pennsylvania State University Sarah A Pendergrass, PhD Research Associate

More information

Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation

Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation PN 100-9879 A1 TECHNICAL NOTE Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation Introduction Cancer is a dynamic evolutionary process of which intratumor genetic and phenotypic

More information

NECC History. Karl V. Steiner 2011 Annual NECC Meeting, Orono, Maine March 15, 2011

NECC History. Karl V. Steiner 2011 Annual NECC Meeting, Orono, Maine March 15, 2011 NECC History Karl V. Steiner 2011 Annual NECC Meeting, Orono, Maine March 15, 2011 EPSCoR Cyberinfrastructure Workshop First regional NENI (now NECC) Workshop held in Vermont in August 2007 Workshop heldinkentucky

More information

History of DNA Sequencing & Current Applications

History of DNA Sequencing & Current Applications History of DNA Sequencing & Current Applications Christopher McLeod President & CEO, 454 Life Sciences, A Roche Company IMPORTANT NOTICE Intended Use Unless explicitly stated otherwise, all Roche Applied

More information

SMRT Analysis v2.2.0 Overview. 1. SMRT Analysis v2.2.0. 1.1 SMRT Analysis v2.2.0 Overview. Notes:

SMRT Analysis v2.2.0 Overview. 1. SMRT Analysis v2.2.0. 1.1 SMRT Analysis v2.2.0 Overview. Notes: SMRT Analysis v2.2.0 Overview 100 338 400 01 1. SMRT Analysis v2.2.0 1.1 SMRT Analysis v2.2.0 Overview Welcome to Pacific Biosciences' SMRT Analysis v2.2.0 Overview 1.2 Contents This module will introduce

More information

Genotyping by sequencing and data analysis. Ross Whetten North Carolina State University

Genotyping by sequencing and data analysis. Ross Whetten North Carolina State University Genotyping by sequencing and data analysis Ross Whetten North Carolina State University Stein (2010) Genome Biology 11:207 More New Technology on the Horizon Genotyping By Sequencing Timeline 2007 Complexity

More information

Genomics and the EHR. Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation

Genomics and the EHR. Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation Genomics and the EHR Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation Overview EHR from Commercial Perspective What can be done TODAY? What could be done TOMORROW? What are some

More information

TruSeq Custom Amplicon v1.5

TruSeq Custom Amplicon v1.5 Data Sheet: Targeted Resequencing TruSeq Custom Amplicon v1.5 A new and improved amplicon sequencing solution for interrogating custom regions of interest. Highlights Figure 1: TruSeq Custom Amplicon Workflow

More information

School of Nursing. Presented by Yvette Conley, PhD

School of Nursing. Presented by Yvette Conley, PhD Presented by Yvette Conley, PhD What we will cover during this webcast: Briefly discuss the approaches introduced in the paper: Genome Sequencing Genome Wide Association Studies Epigenomics Gene Expression

More information

Software Getting Started Guide

Software Getting Started Guide Software Getting Started Guide For Research Use Only. Not for use in diagnostic procedures. P/N 001-097-569-03 Copyright 2010-2013, Pacific Biosciences of California, Inc. All rights reserved. Information

More information

New generation sequencing: current limits and future perspectives. Giorgio Valle CRIBI - Università di Padova

New generation sequencing: current limits and future perspectives. Giorgio Valle CRIBI - Università di Padova New generation sequencing: current limits and future perspectives Giorgio Valle CRIBI Università di Padova Around 2004 the Race for the 1000$ Genome started A few questions... When? How? Why? Standard

More information

FOR REFERENCE PURPOSES

FOR REFERENCE PURPOSES BIOO LIFE SCIENCE PRODUCTS FOR REFERENCE PURPOSES This manual is for Reference Purposes Only. DO NOT use this protocol to run your assays. Periodically, optimizations and revisions are made to the kit

More information

Computational Genomics. Next generation sequencing (NGS)

Computational Genomics. Next generation sequencing (NGS) Computational Genomics Next generation sequencing (NGS) Sequencing technology defies Moore s law Nature Methods 2011 Log 10 (price) Sequencing the Human Genome 2001: Human Genome Project 2.7G$, 11 years

More information

An Introduction to Next-Generation Sequencing for in vitro Fertilization

An Introduction to Next-Generation Sequencing for in vitro Fertilization An Introduction to Next-Generation Sequencing for in vitro Fertilization www.illumina.com/ivfprimer Table of Contents Part I. Welcome to Next-Generation Sequencing 3 NGS for in vitro Fertilization 3 Part

More information

Big data in cancer research : DNA sequencing and personalised medicine

Big data in cancer research : DNA sequencing and personalised medicine Big in cancer research : DNA sequencing and personalised medicine Philippe Hupé Conférence BIGDATA 04/04/2013 1 - Titre de la présentation - nom du département émetteur et/ ou rédacteur - 00/00/2005 Deciphering

More information

Overview of Next Generation Sequencing platform technologies

Overview of Next Generation Sequencing platform technologies Overview of Next Generation Sequencing platform technologies Dr. Bernd Timmermann Next Generation Sequencing Core Facility Max Planck Institute for Molecular Genetics Berlin, Germany Outline 1. Technologies

More information

Core Facility Genomics

Core Facility Genomics Core Facility Genomics versatile genome or transcriptome analyses based on quantifiable highthroughput data ascertainment 1 Topics Collaboration with Harald Binder and Clemens Kreutz Project: Microarray

More information

Worldwide Collaborations in Molecular Profiling

Worldwide Collaborations in Molecular Profiling Worldwide Collaborations in Molecular Profiling Lillian L. Siu, MD Director, Phase I Program and Cancer Genomics Program Princess Margaret Cancer Centre Lillian Siu, MD Contracted Research: Novartis, Pfizer,

More information

14/12/2012. HLA typing - problem #1. Applications for NGS. HLA typing - problem #1 HLA typing - problem #2

14/12/2012. HLA typing - problem #1. Applications for NGS. HLA typing - problem #1 HLA typing - problem #2 www.medical-genetics.de Routine HLA typing by Next Generation Sequencing Kaimo Hirv Center for Human Genetics and Laboratory Medicine Dr. Klein & Dr. Rost Lochhamer Str. 9 D-8 Martinsried Tel: 0800-GENETIK

More information

UCLA Team Sequences Cell Line, Puts Open Source Software Framework into Production

UCLA Team Sequences Cell Line, Puts Open Source Software Framework into Production Page 1 of 6 UCLA Team Sequences Cell Line, Puts Open Source Software Framework into Production February 05, 2010 Newsletter: BioInform BioInform - February 5, 2010 By Vivien Marx Scientists at the department

More information

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16 Course Director: Dr. Barry Grant (DCM&B, bjgrant@med.umich.edu) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems

More information

Illumina Sequencing Technology

Illumina Sequencing Technology Illumina Sequencing Technology Highest data accuracy, simple workflow, and a broad range of applications. Introduction Figure 1: Illumina Flow Cell Illumina sequencing technology leverages clonal array

More information

14.3 Studying the Human Genome

14.3 Studying the Human Genome 14.3 Studying the Human Genome Lesson Objectives Summarize the methods of DNA analysis. State the goals of the Human Genome Project and explain what we have learned so far. Lesson Summary Manipulating

More information

Adding Clinical Services to a Research Core Lab at the UW-Madison. Josh Hyman, Director UWBC DNA Sequencing Facility

Adding Clinical Services to a Research Core Lab at the UW-Madison. Josh Hyman, Director UWBC DNA Sequencing Facility Adding Clinical Services to a Research Core Lab at the UW-Madison Josh Hyman, Director UWBC DNA Sequencing Facility Impetus UW researchers/clinicians becoming interested in moving more discoveries from

More information

Practical Solutions for Big Data Analytics

Practical Solutions for Big Data Analytics Practical Solutions for Big Data Analytics Ravi Madduri Computation Institute (madduri@anl.gov) Paul Dave (pdave@uchicago.edu) Dinanath Sulakhe (sulakhe@uchicago.edu) Alex Rodriguez (arodri7@uchicago.edu)

More information

Rapid Aneuploidy and CNV Detection in Single Cells using the MiSeq System

Rapid Aneuploidy and CNV Detection in Single Cells using the MiSeq System i Technical Note: Reproductive Health Rapid Aneuploidy and CNV Detection in Single Cells using the MiSeq System Comparison between data generated from single cells using 24sure array-based screening and

More information

How Sequencing Experiments Fail

How Sequencing Experiments Fail How Sequencing Experiments Fail v1.0 Simon Andrews simon.andrews@babraham.ac.uk Classes of Failure Technical Tracking Library Contamination Biological Interpretation Something went wrong with a machine

More information

Overview. Overarching observations

Overview. Overarching observations Overview Genomics and Health Information Technology Systems: Exploring the Issues April 27-28, 2011, Bethesda, MD Brief Meeting Summary, prepared by Greg Feero, M.D., Ph.D. (planning committee chair) The

More information

Genetic diagnostics the gateway to personalized medicine

Genetic diagnostics the gateway to personalized medicine Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed

More information

DNA Sequencing & The Human Genome Project

DNA Sequencing & The Human Genome Project DNA Sequencing & The Human Genome Project An Endeavor Revolutionizing Modern Biology Jutta Marzillier, Ph.D Lehigh University Biological Sciences November 13 th, 2013 Guess, who turned 60 earlier this

More information

Genomic Testing: Actionability, Validation, and Standard of Lab Reports

Genomic Testing: Actionability, Validation, and Standard of Lab Reports Genomic Testing: Actionability, Validation, and Standard of Lab Reports emerge: Laura Rasmussen-Torvik Reaction: Heidi Rehm Summary: Dick Weinshilboum Panel: Murray Brilliant, David Carey, John Carpten,

More information

Next Generation Sequencing for DUMMIES

Next Generation Sequencing for DUMMIES Next Generation Sequencing for DUMMIES Looking at a presentation without the explanation from the author is sometimes difficult to understand. This document contains extra information for some slides that

More information

Dr Alexander Henzing

Dr Alexander Henzing Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander

More information

European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute

European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute Justin Paschall Team Leader Genetic Variation / EGA ! European Genome-phenome

More information

Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research. March 17, 2011 Rendez-Vous Séquençage

Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research. March 17, 2011 Rendez-Vous Séquençage Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research March 17, 2011 Rendez-Vous Séquençage Presentation Overview Core Technology Review Sequence Enrichment Application

More information

NIH/NIGMS Trainee Forum: Computational Biology and Medical Informatics at Georgia Tech

NIH/NIGMS Trainee Forum: Computational Biology and Medical Informatics at Georgia Tech ACM-BCB 2015 (Sept. 10 th, 10:00am-12:30pm) NIH/NIGMS Trainee Forum: Computational Biology and Medical Informatics at Georgia Tech Chair: Professor Greg Gibson Georgia Institute of Technology Co-Chair:

More information

Using Illumina BaseSpace Apps to Analyze RNA Sequencing Data

Using Illumina BaseSpace Apps to Analyze RNA Sequencing Data Using Illumina BaseSpace Apps to Analyze RNA Sequencing Data The Illumina TopHat Alignment and Cufflinks Assembly and Differential Expression apps make RNA data analysis accessible to any user, regardless

More information

Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director

Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director Gene expression depends upon multiple factors Gene Transcription

More information

Complete Genomics Sequencing

Complete Genomics Sequencing TECHNOLOGY OVERVIEW Complete Genomics Sequencing Introduction With advances in nanotechnology, high-throughput instruments, and large-scale computing, it has become possible to sequence a complete human

More information

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System White Paper Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System Abstract: This paper describes QIAGEN s philosophy and process for developing

More information

Accelerate genomic breakthroughs in microbiology. Gain deeper insights with powerful bioinformatic tools.

Accelerate genomic breakthroughs in microbiology. Gain deeper insights with powerful bioinformatic tools. Accelerate genomic breakthroughs in microbiology. Gain deeper insights with powerful bioinformatic tools. Empowering microbial genomics. Extensive methods. Expansive possibilities. In microbiome studies

More information

AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE

AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS

More information

Urinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren

Urinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren Urinalysis Compliance Tools POCC Webinar January 19, 2011 Dr. Susan Selgren Learning Objectives Be able to review and improve upon a laboratory plan for compliance including: Competency Documentation Proficiency

More information

Handling next generation sequence data

Handling next generation sequence data Handling next generation sequence data a pilot to run data analysis on the Dutch Life Sciences Grid Barbera van Schaik Bioinformatics Laboratory - KEBB Academic Medical Center Amsterdam Very short intro

More information

Introduction To Real Time Quantitative PCR (qpcr)

Introduction To Real Time Quantitative PCR (qpcr) Introduction To Real Time Quantitative PCR (qpcr) SABiosciences, A QIAGEN Company www.sabiosciences.com The Seminar Topics The advantages of qpcr versus conventional PCR Work flow & applications Factors

More information

Towards Integrating the Detection of Genetic Variants into an In-Memory Database

Towards Integrating the Detection of Genetic Variants into an In-Memory Database Towards Integrating the Detection of Genetic Variants into an 2nd International Workshop on Big Data in Bioinformatics and Healthcare Oct 27, 2014 Motivation Genome Data Analysis Process DNA Sample Base

More information

How many of you have checked out the web site on protein-dna interactions?

How many of you have checked out the web site on protein-dna interactions? How many of you have checked out the web site on protein-dna interactions? Example of an approximately 40,000 probe spotted oligo microarray with enlarged inset to show detail. Find and be ready to discuss

More information

Next Generation Sequencing; Technologies, applications and data analysis

Next Generation Sequencing; Technologies, applications and data analysis ; Technologies, applications and data analysis Course 2542 Dr. Martie C.M. Verschuren Research group Analysis techniques in Life Science, Breda Prof. dr. Johan T. den Dunnen Leiden Genome Technology Center,

More information

The NGS IT notes. George Magklaras PhD RHCE

The NGS IT notes. George Magklaras PhD RHCE The NGS IT notes George Magklaras PhD RHCE Biotechnology Center of Oslo & The Norwegian Center of Molecular Medicine University of Oslo, Norway http://www.biotek.uio.no http://www.ncmm.uio.no http://www.no.embnet.org

More information

Automated Library Preparation for Next-Generation Sequencing

Automated Library Preparation for Next-Generation Sequencing Buyer s Guide: Automated Library Preparation for Next-Generation Sequencing What to consider as you evaluate options for automating library preparation. Yes, success can be automated. Next-generation sequencing

More information

Big Data An Opportunity or a Distraction? Signal or Noise?

Big Data An Opportunity or a Distraction? Signal or Noise? Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28

More information

Sanger Sequencing and Quality Assurance. Zbigniew Rudzki Department of Pathology University of Melbourne

Sanger Sequencing and Quality Assurance. Zbigniew Rudzki Department of Pathology University of Melbourne Sanger Sequencing and Quality Assurance Zbigniew Rudzki Department of Pathology University of Melbourne Sanger DNA sequencing The era of DNA sequencing essentially started with the publication of the enzymatic

More information

Cloud Computing Solutions for Genomics Across Geographic, Institutional and Economic Barriers

Cloud Computing Solutions for Genomics Across Geographic, Institutional and Economic Barriers Cloud Computing Solutions for Genomics Across Geographic, Institutional and Economic Barriers Ntinos Krampis Asst. Professor J. Craig Venter Institute kkrampis@jcvi.org http://www.jcvi.org/cms/about/bios/kkrampis/

More information

High Performance Compu2ng Facility

High Performance Compu2ng Facility High Performance Compu2ng Facility Center for Health Informa2cs and Bioinforma2cs Accelera2ng Scien2fic Discovery and Innova2on in Biomedical Research at NYULMC through Advanced Compu2ng Efstra'os Efstathiadis,

More information

Concepts and methods in sequencing and genome assembly

Concepts and methods in sequencing and genome assembly BCM-2004 Concepts and methods in sequencing and genome assembly B. Franz LANG, Département de Biochimie Bureau: H307-15 Courrier électronique: Franz.Lang@Umontreal.ca Outline 1. Concepts in DNA and RNA

More information